Education
About Us
Working with TipRanks
Follow Us
Predictmedix (TSE:PMED)
:PMED
PMED Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.06
Previous CloseN/A
Volume143.53K
Average Volume (3M)287.08K
Market Cap
$3.85M
Enterprise ValueC$3.01M
Total Cash (Recent Filing)$28.79K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Sep 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding192,534,550
10 Day Avg. Volume349,673
30 Day Avg. Volume287,081
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.78
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-18.26
Enterprise Value/Ebitda-1.85
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Predictmedix News
PMED FAQ
What was Predictmedix’s price range in the past 12 months?
Predictmedix lowest stock price was <C$0.01 and its highest was C$0.06 in the past 12 months.
What is Predictmedix’s market cap?
Predictmedix’s market cap is $3.85M.
When is Predictmedix’s upcoming earnings report date?
Predictmedix’s upcoming earnings report date is Sep 26, 2025 which is in 40 days.
How were Predictmedix’s earnings last quarter?
Currently, no data Available
Is Predictmedix overvalued?
According to Wall Street analysts Predictmedix’s price is currently Overvalued.
Does Predictmedix pay dividends?
Predictmedix does not currently pay dividends.
What is Predictmedix’s EPS estimate?
Predictmedix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Predictmedix have?
Predictmedix has 192,534,550 shares outstanding.
What happened to Predictmedix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Predictmedix?
Currently, no hedge funds are holding shares in TSE:PMED
Company Description
Predictmedix
Predictmedix (PMED) is a technology company that operates in the healthcare sector, specializing in artificial intelligence (AI) driven solutions. The company focuses on developing AI-powered technologies designed to enhance workplace health and safety. Its core products include impairment detection systems and solutions for rapid health assessments, aiming to improve safety and efficiency across various industries.
Technical Analysis
Ownership Overview
14.89% Insiders
―
Mutual Funds
― Other Institutional Investors
85.11% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---